AMERICAN ORIENTL BIO (AOB)
The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.
Recs
Upthumb. Traditional medicine products in China. Excellent cash flow. Huge sales growth. Low to nominal debt ratio. Lots of cash on-hand. Ascencio short with large short ratio. Ascencio doesn't like their lack of disclosure of subsidiaries.
Recs
Current 5.43, Sept 19 09. Limit 5.11
Recs
Recs
Growth in the right place
Recs
high risk but i believe this will be a high reward with growth multipling over the next decade
Recs
Peg .5, ROE 23%, 27% insiders, projected 5 years earnings 32%-a good value play and growth stock.
Recs
HIdden Gem trading near 52 week low with great upside potential over the next several years. As Chinese discretionary income increases, the Chinese will spend more on healthcare.
Recs
Currently trading at 46% intrinsic value.
Recs
AOB @ $5 now...presume goes to $6 again in a short period.
Recs
This stock has been doing crazy antics on little or no information. However, it has a solid product, good cash reserves and OUGHT to be performing much better. Long term buy and hold.
Recs
Recs
great business to own, buy and hold forever
Recs
Based on insider trading and earnings estimates
Recs
Looks healthy and appealing. It atleast should outperform.
Recs
Chinese supplements and herbs and snake oil. The chinese love them.
Recs
Seems like they've been successful at marketing their products so far. I guess I'm picking outperform here just because of the company's numbers, not because I believe in their superior product. Maybe this counts as diversification.
Note: This is not at all in line with my CAPS strategy, but it turns out finding 200 stocks with no debt, good returns and whose product I believe to be superior to competition is not that easy.
Recs
east meets west
Recs
with chinas economy expanding everyday, the people of china will have a chance to invest time and effort into health.
Recs
Well, I'm not sure AOB will bring "greater happiness, health and love to the world!" as its website states, but it certainly ought to bring in plenty of money for investors over the long-term!
This company is financially stable (0.89 debt/equity ratio), highly profitable (18.1% net margin vs. -54.32% sector average), able to generate cash (0.64 cash flow/share), and keeps on growing (+66% revenues and +33% earnings over the last 5 years). These fundamentals remain the same, only the stock is at a bargain price now.
Finally, China will most likely continue to grow at fast rates in 2010 and beyond and AOB will be in the thick of it!
Recs
Cie with a wide presence in the medicine-pharma market in China. Good earning growth. Optionable stock.Stock price under 10$

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 469 1 2 3 4 5 6 7 8 9 10 Next »